Drugmakers Novo Nordisk and Pfizer raised their offers in the multibillion-dollar takeover battle for obesity-drug developer ...
The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through ...
The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.
A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback